MIDOL and Related OTC Menstrual Relief Products Recalled for Temperature Storage Deviation
Family Dollar Stores recalled MIDOL COMPLETE, QP MENSTRUAL RELIEF, and QP PMS FORMULA caplets distributed April–June 2022 due to CGMP deviations from improper storage temperature.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a precautionary CGMP deviation related to storage temperature, which is a manufacturing process issue without confirmed harm to consumers.
Plain-English summary
Family Dollar Stores, LLC is recalling MIDOL COMPLETE CAPLET 16 CT (SKU 913028), QP MENSTRUAL RELIEF COMPLETE CAPLET 16CT (SKU 999982), and QP PMS FORMULA CAPLET 32 CT (SKU 913232) due to Current Good Manufacturing Practice (CGMP) deviations. The recall was initiated because these over-the-counter pain relief products were held outside appropriate storage temperature conditions.
The affected products were distributed to select Family Dollar Stores from April 30, 2022 through June 10, 2022. Improper storage temperature can potentially affect the stability and efficacy of the medications.
Consumers who purchased these products should discontinue use and discard them. For additional information or questions, consumers may contact Family Dollar Stores, LLC.
The recalled product
- Product
- MIDOL COMPLETE CAPLET 16 CT SKU 913028 QP MENSTRUAL RELIEF COMPLETE CAPLET 16CT SKU 999982 QP PMS FORMULA CAPLET 32 CT SKU 913232 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- temperature-deviation
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- SKUs: 913028
- 999982
- SKUs: 913232
- 913028
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27